Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Somlo

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|May 1, 1992
Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancerE M Newman, S A Akman, J S Harrison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2009
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantationV Pullarkat, M L Slovak, A Dagis, et al.
Bone Marrow Transplantation|June 13, 2000
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.
Gynecologic Oncology|June 1, 2000
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-upR J Morgan, P Braly, L Leong, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapyR J Morgan, T Synold, B I Carr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Breast Cancer Research and Treatment|November 2, 2011
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerG Somlo, C L Martel, S K Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignanciesM L Tetef, T W Synold, W Chow, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|May 1, 1992
Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancerE M Newman, S A Akman, J S Harrison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2009
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantationV Pullarkat, M L Slovak, A Dagis, et al.
Bone Marrow Transplantation|June 13, 2000
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.
Gynecologic Oncology|June 1, 2000
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-upR J Morgan, P Braly, L Leong, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapyR J Morgan, T Synold, B I Carr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Breast Cancer Research and Treatment|November 2, 2011
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerG Somlo, C L Martel, S K Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignanciesM L Tetef, T W Synold, W Chow, et al.
Pageof 7